GPI and T-cell non-Hodgkin lymphoma: Conversely, in NK/T-cell lymphoma, SIRT5 functions as a tumor suppressor by desuccinylation and destabilization of glucose-6-phosphate isomerase (GPI), thereby inhibiting glycolytic flux and tumor growth (140).